{'fraction_non_alphanumeric': 0.0185546875, 'fraction_numerical': 0.001953125, 'mean_word_length': 5.366459627329193, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The next frontier of combating drug addiction in
America

While pre-COVID-19 data indicated that the massive public
health effort to fight the opioid epidemic was beginning to
gain ground, the record-breaking surge of overdose deaths
during the pandemic revealed that the underlying state of our
addiction prevention and care system remains insufficient.
This reality has demanded a rethinking of approaches – both
policy-based and scientific – to accelerate the reversal of the
crisis. Evolving harm reduction policies based in a greater
appreciation for the neuroscience of addiction represent a
positive shift in our approach to addressing addiction. Yet,
there is still much opportunity for improvement, especially
in expanding the use of medication assisted treatment (MAT)
to treat opioid addiction. Moreover, emerging neuroscience
research may offer new paths to treatment and prevention.
Collectively, these efforts have the potential to significantly
tip the balance in the battle against drug addiction in
America.